# Intermittent fasting for weight loss: what trials measured

Source: https://pepvault.app/guides/intermittent-fasting-weight-loss

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# Intermittent fasting for weight and fat loss: what the trials measured

Reviewed November 2026 15 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

How much weight and fat intermittent fasting lost in the trials (16:8, 5:2, 4:3, alternate-day), set in one table beside the semaglutide and tirzepatide trials.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 15
- **Questions:** 6
- **Compounds:** 2

## The short answer

In randomized trials, intermittent fasting (a daily eating window, 5:2, 4:3 or alternate-day fasting) lost about 3% of body weight in 8 weeks and about 5 to 8% over a year, close to what daily calorie cutting loses. About three-quarters of the loss was fat. The GLP-1 trials went further: semaglutide lost 14.9% at 68 weeks, tirzepatide up to 20.9% at 72.

- The best year-long fasting result is 7.6% of body weight, from a 4:3 plan with intensive coaching.
- In the drug trials the placebo groups also dieted and exercised, and lost 2.4 to 5.7%; the drug groups lost 14.9 to 20.9%.
- Fasting and the drugs both lose roughly three parts fat to one part lean tissue; what differs is how much.
- No trial has put fasting and a GLP-1 head to head.

Every number checked at its primary source · Nov 20, 2026 · [15 sources](https://pepvault.app/guides/intermittent-fasting-weight-loss#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Randomized trials of intermittent fasting (8 weeks to 12 months), a 2026 Cochrane review of 22 trials and a 2025 network meta-analysis of 99; the GLP-1 numbers are from the phase 3 STEP 1, STEP 3 and SURMOUNT-1 trials and the Wegovy label. No trial has compared fasting with a GLP-1 directly.

## How much weight does intermittent fasting lose?

Between 3% and 8% of body weight, depending on the plan and how long it ran. Intermittent fasting means you change when you eat: all food inside a daily window (time-restricted eating, such as 16:8), or very little on set days of the week (5:2, 4:3, alternate-day fasting). These are the randomized trials (pepvault.app/glossary/randomized-controlled-trial) that measured it in adults with overweight or obesity.

| Trial | Plan | Who and how long | Weight lost |
| --- | --- | --- | --- |
| Cienfuegos 2020 | Eating only 3 to 7 p.m. or 1 to 7 p.m., no calorie counting | 58 adults with obesity, 8 weeks | −3.2% from the start in both window groups; controls +0.1%[1](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-1) |
| Jamshed 2022 | Eating 7 a.m. to 3 p.m., plus a calorie cut | 90 adults with obesity, 14 weeks | −6.3 kg from the start; −4.0 kg with the same cut over 12 or more hours[2](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-2) |
| Harvie 2011 | 5:2, about 650 kcal (2,710 kJ) on 2 days a week | 107 premenopausal women, 6 months | −6.4 kg from the start; −5.6 kg on a daily cut[3](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-3) |
| Trepanowski 2017 | Alternate-day: 25% of energy needs on fast days, 125% on the others | 100 adults with obesity, 12 months | −6.8% at 6 months, −6.0% at 12, both against controls[4](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-4) |
| Lin 2023 | Eating noon to 8 p.m., no calorie counting | 90 adults with obesity, 12 months | −4.87% against controls[5](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-5) |
| Liu 2022 | Eating 8 a.m. to 4 p.m., plus a calorie cap | 139 adults with obesity, 12 months | −8.0 kg from the start; −6.3 kg on the calorie cap alone[6](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-6) |
| Catenacci 2025 | 4:3: 80% less energy on 3 days a week, plus coaching | 165 adults with overweight or obesity, 12 months | −7.6% from the start; −5.0% on a matched daily cut[7](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-7) [15](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-15) |

The 4:3 trial is the strongest result so far. Both of its groups had group coaching and were asked to build up to 300 minutes of moderate activity a week; 58% of the 4:3 group lost 5% or more of their weight, against 47% on the daily cut[7](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-7) [15](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-15). Whether fasting beats plain calorie cutting across the other trials has its own guide (pepvault.app/guides/intermittent-fasting-on-a-glp-1): in most of them, it did not.

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

PepVault's Body page logs each weigh-in on a trend line toward your goal weight, and tracks body fat and waist with their change since your first entry, from a tape check-in or a smart scale's readings.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## How does intermittent fasting compare with semaglutide and tirzepatide?

The drug trials lost two to three times as much. They also ran longer, and every group in them, the placebo groups included, was on a diet-and-exercise plan. In STEP 1 and SURMOUNT-1 that plan aimed for 500 kcal a day less food and at least 150 minutes of activity a week[9](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-9) [10](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-10). In STEP 3 everyone started on 1,000 to 1,200 kcal a day for 8 weeks, then 1,200 to 1,800, with activity built up to 200 minutes a week[10](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-10).

| Trial | Treatment | Length | Weight lost | Share who lost 5%, 10% or 20% or more |
| --- | --- | --- | --- | --- |
| Catenacci 2025 | 4:3 fasting with coaching | 12 months | −7.6%[7](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-7) | 5% or more: 58%[15](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-15) |
| STEP 1 | Placebo, with diet and activity advice | 68 weeks | −2.4%[8](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-8) | 10% or more: 12%[10](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-10) |
| STEP 3 | Placebo, with an intensive diet program | 68 weeks | −5.7%[10](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-10) | 10% or more: 27.1%[10](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-10) |
| SURMOUNT-1 | Placebo, with diet and activity advice | 72 weeks | −3.1%[9](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-9) | Lost 20% or more: 3%[9](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-9) |
| STEP 1 | Semaglutide 2.4 mg weekly | 68 weeks | −14.9%, or −15.3 kg[8](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-8) | 10% or more: 66.1%[10](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-10) |
| STEP 3 | Semaglutide 2.4 mg weekly, intensive program | 68 weeks | −16%[10](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-10) | 10% or more: 73%[10](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-10) |
| SURMOUNT-1 | Tirzepatide 5, 10 or 15 mg weekly | 72 weeks | −15.0%, −19.5%, −20.9%[9](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-9) | Lost 20% or more: 50% on 10 mg, 57% on 15 mg[9](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-9) |

Read the placebo rows as the dieting groups they were. A strict diet with intensive support lost 5.7% at 68 weeks in STEP 3, inside the fasting trials' range[10](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-10). The doses in the table are the trials' doses, given as that.

These trials enrolled different people and were never run against each other, so the table sets their numbers side by side; it is not a head-to-head result. As of November 2026 no trial has compared a fasting plan with a GLP-1 drug.

## How much of the weight lost on intermittent fasting is fat?

Most of it, and about the same share as on a GLP-1. Body scans (DXA, a low-dose X-ray that splits the body into fat, lean tissue and bone) show the split. Lean mass (pepvault.app/glossary/lean-mass) is everything that is not fat or bone: muscle, organs and water.

| Trial | Fat lost | Lean tissue lost | Fat as a share of the loss |
| --- | --- | --- | --- |
| Cienfuegos 2020, 4-hour window, 8 weeks | −2.8 kg | −0.8 kg | About 78%[1](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-1) |
| Cienfuegos 2020, 6-hour window, 8 weeks | −1.4 kg | −1.5 kg | About 48%[1](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-1) |
| Jamshed 2022, early window, 14 weeks | −4.7 kg of −6.3 kg lost | Not given in the summary | About 75%[2](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-2) |
| Harvie 2011, 5:2, 6 months (body-fat scale) | Not given here | Not given here | 79%[3](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-3) |
| SURMOUNT-1 scan group, tirzepatide, 72 weeks | −33.9% of fat mass | −10.9% of lean mass | 74%[11](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-11) |
| SURMOUNT-1 scan group, placebo, 72 weeks | −8.2% of fat mass | −2.6% of lean mass | 75%[11](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-11) |

Outside the 6-hour window group, the pattern holds across very different treatments: roughly three parts fat to one part lean tissue. In SURMOUNT-1's scan group of 160 people, tirzepatide and placebo lost the same three-to-one split, and the drug group lost 21.3% of body weight against 5.3%[11](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-11). So the difference between fasting and a GLP-1 is mostly in how much weight goes, not in what kind. How to hold on to muscle while the weight comes off has its own guide (pepvault.app/guides/muscle-on-a-glp-1).

**Commonly reported:** the first few pounds on a fasting plan go fast, then the scale slows within a few weeks, and strength can dip on fast days or late in a long window.

<!--promo-->

PepVault's Body page logs each weigh-in on a trend line toward your goal weight, and tracks body fat and waist with their change since your first entry, from a tape check-in or a smart scale's readings. [Track your weight in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-intermittent-fasting-weight-loss-i&mt=8)

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [GIP](https://pepvault.app/glossary/gip)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [Lean mass](https://pepvault.app/glossary/lean-mass)

## Why does fasting lose less than a GLP-1?

Fasting works by eating less, and how much less is up to you every day. In the 4- and 6-hour window trial, people ate about 550 kcal a day less without counting[1](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-1). In the early-window trial, eating from 7 a.m. to 3 p.m. did as much as cutting another 214 kcal a day[2](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-2).

The gap shows when people have to hold the plan themselves. In the alternate-day trial, the fasting group ate more than prescribed on fast days and less on the days in between, and 38% dropped out, against 29% on the daily cut[4](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-4). The 4:3 trial asked both groups for the same weekly deficit, about 34%; measured with doubly labeled water, the 4:3 group came closer to it, and 19% dropped out against 30% on the daily cut[7](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-7) [15](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-15).

A GLP-1 drug turns down hunger itself. The Wegovy label puts it plainly: GLP-1 is a natural regulator of appetite and calorie intake, its receptor sits in the brain areas that control appetite, and the drug also slows how fast the stomach empties[10](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-10). Tirzepatide (pepvault.app/peptides/tirzepatide) adds a second gut hormone, GIP (pepvault.app/glossary/gip). The weekly shot keeps working on hunger whether or not the day's meals were planned around it.

## What do the big reviews say about intermittent fasting for weight loss?

That fasting works about as well as standard diet advice, and better than doing nothing. The 2026 Cochrane review pooled 22 trials and 1,995 adults with overweight or obesity, followed for six to twelve months. Against regular diet advice, fasting differed by 0.33 percentage points of body weight, which the authors call little to no difference. Against no diet or a waiting list, it lost 3.42 percentage points more, which the authors still rate as little to no difference[12](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-12).

A 2025 network meta-analysis (pepvault.app/glossary/meta-analysis) in the BMJ pooled 99 trials and 6,582 adults. Every fasting plan beat eating freely. Alternate-day fasting beat daily calorie cutting by 1.29 kg, mostly in short trials; in trials of 24 weeks or longer, no plan beat another[13](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-13). Neither review reports a fasting result near the GLP-1 trials' 15 to 21% (the trial pages: pepvault.app/research/semaglutide-step-1-2021 and pepvault.app/research/tirzepatide-surmount-1-2022).

## If you try intermittent fasting, how do you check it is working?

Measure it the way the trials did, so your number can be read against theirs.

1. Pick one plan from the trials and keep its hours or days fixed, such as eating from noon to 8 p.m.[5](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-5), or 5:2 at about 650 kcal on 2 days a week[3](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-3).
2. Weigh yourself first thing in the morning, before food, on the same scale each time.
3. Measure your waist at the start and once a month after, at the same spot each time.
4. At 8 weeks, work out your percent change (kilograms or pounds lost, divided by your starting weight, times 100): about 3% was the typical result at that point[1](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-1).
5. At 12 months, 5 to 8% is in line with the year-long trials[4](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-4) [5](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-5) [7](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-7); in the 4:3 trial, 58% reached 5% or more[15](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-15).
6. Keep protein at each meal and strength training in the week, since about a quarter of the weight lost in these trials was lean tissue[2](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-2) [11](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-11).

<!--promo-->

PepVault's Food page sets one daily protein target from your profile and goal, and counts each meal you log against it. [Track your food in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-intermittent-fasting-weight-loss-i&mt=8)

<!--/promo-->

**When to get help** If you take insulin or a sulfonylurea for diabetes, talk to your prescriber before starting fast days: in the 5:2 trial in type 2 diabetes, those medicines were cut back at the start, and the medicine plan was tightened after cases of low blood sugar[14](https://pepvault.app/guides/intermittent-fasting-weight-loss#source-14).

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Cienfuegos S, Gabel K, Kalam F, et al. Effects of 4- and 6-h time-restricted feeding on weight and cardiometabolic health: a randomized controlled trial in adults with obesity. Cell Metab. 2020;32(3):366-378.e3. [PubMed 32673591](https://pubmed.ncbi.nlm.nih.gov/32673591/)
2. Jamshed H, Steger FL, Bryan DR, et al. Effectiveness of early time-restricted eating for weight loss, fat loss, and cardiometabolic health in adults with obesity: a randomized clinical trial. JAMA Intern Med. 2022;182(9):953-962. [PubMed 35939311](https://pubmed.ncbi.nlm.nih.gov/35939311/)
3. Harvie MN, Pegington M, Mattson MP, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond). 2011;35(5):714-727. [PubMed 20921964](https://pubmed.ncbi.nlm.nih.gov/20921964/)
4. Trepanowski JF, Kroeger CM, Barnosky A, et al. Effect of alternate-day fasting on weight loss, weight maintenance, and cardioprotection among metabolically healthy obese adults: a randomized clinical trial. JAMA Intern Med. 2017;177(7):930-938. [PubMed 28459931](https://pubmed.ncbi.nlm.nih.gov/28459931/)
5. Lin S, Cienfuegos S, Ezpeleta M, et al. Time-restricted eating without calorie counting for weight loss in a racially diverse population: a randomized controlled trial. Ann Intern Med. 2023;176(7):885-895. [PubMed 37364268](https://pubmed.ncbi.nlm.nih.gov/37364268/)
6. Liu D, Huang Y, Huang C, et al. Calorie restriction with or without time-restricted eating in weight loss. N Engl J Med. 2022;386(16):1495-1504. [PubMed 35443107](https://pubmed.ncbi.nlm.nih.gov/35443107/)
7. Catenacci VA, Ostendorf DM, Pan Z, et al. The effect of 4:3 intermittent fasting on weight loss at 12 months: a randomized clinical trial. Ann Intern Med. 2025;178(5):634-644. [PubMed 40163873](https://pubmed.ncbi.nlm.nih.gov/40163873/)
8. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. [PubMed 33567185](https://pubmed.ncbi.nlm.nih.gov/33567185/)
9. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. [PubMed 35658024](https://pubmed.ncbi.nlm.nih.gov/35658024/)
10. Novo Nordisk. WEGOVY (semaglutide) injection and tablets, prescribing information (DailyMed, version 19, effective June 18, 2026): sections 12.1 and 14, Table 8 (its Studies 2 and 4 are STEP 1 and STEP 3). [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
11. Look M, Dunn JP, Kushner RF, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Diabetes Obes Metab. 2025;27(5):2720-2729. [PubMed 39996356](https://pubmed.ncbi.nlm.nih.gov/39996356/)
12. Garegnani LI, Oltra G, Ivaldi D, et al. Intermittent fasting for adults with overweight or obesity. Cochrane Database Syst Rev. 2026;2(2):CD015610. [PubMed 41692034](https://pubmed.ncbi.nlm.nih.gov/41692034/)
13. Semnani-Azad Z, Khan TA, Chiavaroli L, et al. Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials. BMJ. 2025;389:e082007. [PubMed 40533200](https://pubmed.ncbi.nlm.nih.gov/40533200/)
14. Carter S, Clifton PM, Keogh JB. Effect of intermittent compared with continuous energy restricted diet on glycemic control in patients with type 2 diabetes: a randomized noninferiority trial. JAMA Netw Open. 2018;1(3):e180756. [PubMed 30646030](https://pubmed.ncbi.nlm.nih.gov/30646030/)
15. University of Colorado Anschutz Medical Campus. Intermittent fasting outperforms calorie counting in weight loss study (news release on Catenacci 2025, with the investigators' figures), 2025. [news.cuanschutz.edu](https://news.cuanschutz.edu/news-stories/intermittent-fasting-outperforms-calorie-counting-in-weight-loss-study)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)

Yes: Ozempic and Mounjaro were tested on top of metformin, and no label lists it as an interaction. What the five labels flag, side by side, and when to call.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)

## Related guides

- Guide · GLP-1s

  ### [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)

  Intermittent fasting on a GLP-1: what the fasting trials found, why no trial has tested the pair, and what the labels say on blood sugar, fluids and protein.

  Read the guide
- Guide · Hormones and blood tests

  ### [Intermittent fasting in women: what the studies included](https://pepvault.app/guides/intermittent-fasting-in-women)

  Intermittent fasting in women: who the main trials enrolled (share of women, ages, menopause) and what they found for weight, DHEA, estradiol and the cycle.

  Read the guide
- Guide · GLP-1s

  ### [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)

  How much weight lost on a GLP-1 is lean mass: SURMOUNT-1, STEP 1, the apitegromab and bimagrumab add-on trials, and what guidance says on protein and training.

  Read the guide
- Guide · Longevity and supplements

  ### [Calorie restriction and longevity: what the animal and human trials show](https://pepvault.app/guides/calorie-restriction-and-longevity)

  Eating less made mice and monkeys live longer. In people, a 12% cut over 2 years lowered LDL and blood pressure and slowed an aging clock 2-3%, but cost bone.

  Read the guide
- Guide · GLP-1s

  ### [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)

  How much protein a day by body weight and goal: the 0.8 g/kg minimum, the new 1.2 to 1.6 g/kg Dietary Guidelines goal, and more on a diet, lifting or after 65.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [GIP](https://pepvault.app/glossary/gip)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [Lean mass](https://pepvault.app/glossary/lean-mass)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
